Skip to main content
Morepen Laboratories Ltd. logo

Morepen Laboratories Ltd. — Investor Relations & Filings

Ticker · MOREPENLAB ISIN · INE083A01026 LEI · 335800OJZDFHFQJ4HP35 BSE.NS Manufacturing
Filings indexed 1,660 across all filing types
Latest filing 2024-03-13 Regulatory Filings
Country IN India
Listing BSE.NS MOREPENLAB

About Morepen Laboratories Ltd.

https://www.morepen.com

Morepen Laboratories Ltd. is a research-led company specializing in the development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs), home diagnostic devices, and finished formulations. The company maintains a significant global presence, exporting high-quality APIs such as Loratadine, Montelukast, Atorvastatin, and Fexofenadine to numerous international markets. Its diagnostic division, branded as Dr. Morepen, is a prominent player in the home healthcare segment, offering a wide range of products including digital glucometers, blood pressure monitors, and nebulizers. Morepen operates manufacturing facilities compliant with international regulatory standards, including USFDA approvals. The company focuses on leveraging its R&D capabilities to deliver healthcare solutions and maintains a diverse portfolio across various therapeutic areas including cardiovascular, anti-diabetic, and anti-asthmatic treatments.

Recent filings

Filing Released Lang Actions
Issuance of letter of confirmation against duplicate share certificate
Regulatory Filings
2024-03-13 English
Loss of Share Certificates
Regulatory Filings
2024-03-09 English
Intimation of loss of share certificate
Regulatory Filings
2024-03-09 English
Change in Management
Board/Management Information Classification · 100% confidence The document is a formal disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding a change in senior management personnel. It announces the promotion of Mrs. Amita Sharma to Chief Operating Officer - API effective 1st March 2024. The document includes details required by SEBI circular for such management changes. There is no financial data, earnings information, or report attached or referenced. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2024-03-01 English
Please find attached details of change in senior management personnel - promotion
Board/Management Information Classification · 100% confidence The document is a formal disclosure submitted to stock exchanges (NSE and BSE) under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It announces a change in senior management personnel, specifically the promotion of Mrs. Amita Sharma to Chief Operating Officer. The document includes details required by SEBI circulars about the change in management. There is no financial data, no report attached or referenced, and the content is focused solely on management personnel change. Therefore, this fits the category of Board/Management Information (MANG). The document length is short and it is not an announcement of a report publication or certification, so it is not RPA or RNS.
2024-03-01 English
Loss of Share Certificates
Regulatory Filings
2024-02-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.